Figure 1: Serum levels of IP-10, IFN-γ, IL-4, and TGF-β1 as well as the IFN-γ/IL-4 ratio in chronic hepatitis B patients with or without fibrosis. | Scientific Reports

Figure 1: Serum levels of IP-10, IFN-γ, IL-4, and TGF-β1 as well as the IFN-γ/IL-4 ratio in chronic hepatitis B patients with or without fibrosis.

From: Predictive Value of Serum IFN-γ inducible Protein-10 and IFN-γ/IL-4 Ratio for Liver Fibrosis Progression in CHB Patients

Figure 1

The levels of serum IP-10, IFN-γ, IL-4, and TGF-β1 in CHB patients with or without liver fibrosis were determined by ELISA, and the IFN-γ/IL-4 ratio was calculated. ♦♦♦Differs from controls (the F0 group), P < 0.05; ★★★differs from mild or minimal fibrosis (the F1–2 group), P < 0.05; ▴▴▴differs from moderate fibrosis (the F3–4 group), P < 0.05. (a) IP-10; (b) IFN-γ; (c) IL-4; (d) TGF-β1; (e) the IFN-γ/IL-4 ratio.

Back to article page